|
TWICE-WEEKLY BRIEFING
Tuesday, July 28, 2026
Issue 260728-50
|
|
| The MOC Brief |
| Health policy, priced and translated for self-funded plan sponsors |
|
| Five moves, one theme: federal payers are pushing cost, integrity, and disclosure risk down onto states, plans, hospitals, and vendors. |
| |
IN THIS EDITION
| 1. |
CMS proposes a $246 billion Medicaid provider tax phase-down |
| 2. |
HHS defers $1.07 billion over program integrity concerns |
| 3. |
Generic drug tariffs get a 2028 start date |
| 4. |
House and Senate advance twin price transparency bills |
| 5. |
Medicare moves to end pay for outsourced remote monitoring |
|
|
|
1
|
MEDICAID POLICY
| July 21, 2026
|
| CMS Proposes a $246 Billion Medicaid Provider Tax Phase-Down |
| CMS released a Notice of Proposed Rulemaking implementing Section 71115 of the One Big Beautiful Bill Act, capping new provider taxes and phasing the indirect hold harmless threshold down from 6 percent to 3.5 percent by fiscal year 2032 in Medicaid expansion states. CMS projects the rule will cut federal Medicaid spending by $245.8 billion and state spending by $138.2 billion over ten years, leaving states with a net $60.5 billion deficit as they lose provider tax revenue. Comments are open, and the phase-down begins in FY 2028. |
| |
MOC PERSPECTIVE
The provider tax phase-down is a cost-shift accelerant that lands directly in your commercial claims. Every dollar of federal Medicaid match that disappears is a dollar hospitals will try to recover from self-funded plans through 2027 and 2028 renewals, and expansion states, which cover 40 million enrollees, absorb the sharpest hit.
|
|
| WHAT TO DO NOW |
| ▪ |
Model a 3 to 5 percent commercial rate demand overlay for hospitals in expansion states with heavy provider tax exposure, including California, New York, Michigan, and Pennsylvania. |
| ▪ |
Tighten out-of-network reimbursement floors using the corrected machine-readable files from the 519-hospital enforcement wave. |
| ▪ |
Add a Medicaid shortfall carve-out clause to every 2027 hospital contract that limits pass-through of state budget gaps into commercial rate increases. |
|
|
Source: CMS fact sheet, CMS-2452-P
|
|
|
2
|
PROGRAM INTEGRITY
| July 21, 2026
|
| HHS Defers $1.07 Billion in Payments to California and Minnesota |
| HHS and CMS deferred approximately $867.5 million in federal Medicaid payments to California and $199 million to Minnesota, citing high-risk claims flagged in 14 service areas, mostly home- and community-based services. CMS is holding the funds pending state documentation and provider integrity reviews, marking the largest single-week federal Medicaid deferral of the Trump administration. Minnesota had previously sued CMS over $2 billion in earlier holds, and that litigation remains paused. |
| |
MOC PERSPECTIVE
Read this deferral as a signal that federal program integrity enforcement, not budget appropriations, is now the primary fiscal control on Medicaid, and that pressure will bleed into commercial and dual-eligible arrangements within 12 months. Home- and community-based services and behavioral health providers absorbing the state cash-flow squeeze will pursue commercial contract terms that recover the shortfall, and plans carrying dual-eligible or SNP populations should expect rate-cell instability.
|
|
| WHAT TO DO NOW |
| ▪ |
Audit every home- and community-based services or behavioral health contract signed since the first quarter of 2026 for cost-shift triggers. |
| ▪ |
Require a program integrity attestation clause in your 2027 vendor agreements. |
| ▪ |
Stress-test the dual-eligible portion of any group Medicare Advantage book against a 6 to 9 percent state Medicaid rate compression scenario. |
|
|
Source: HHS press room
|
|
|
3
|
PHARMACY COSTS
| July 21 and 22, 2026
|
| Generic Drug Tariffs Get a 2028 Start Date and a 2029 Step-Up |
| President Trump announced that imported generic drugs will face no tariffs through August 2028, then a 100 percent duty for one year, and 200 percent thereafter, with the stated goal of reshoring generic pharmaceutical manufacturing. Generics make up roughly 90 percent of U.S. prescriptions filled, and India supplies more than half. Patented and branded drugs remain unaffected. |
| |
MOC PERSPECTIVE
The tariff clock is a 2028 cost cliff, and you underwrite it starting with your 2027 PBM renewal. A 100 percent tariff on 60 percent of the generic supply base implies a 10 to 15 percent commercial pharmacy spend increase in 2028 even if PBMs pass through nothing, and a 200 percent tariff pushes that to 20 to 30 percent by 2029.
|
|
| WHAT TO DO NOW |
| ▪ |
Require a tariff pass-through cap and a reopener in any 2027 PBM contract. |
| ▪ |
Accelerate migration to NADAC-plus reimbursement with a domestic sourcing preference. |
| ▪ |
Commission a domestic versus imported claims analysis on your top 100 generic NDCs so 2028 formulary steering options are ready before the tariff triggers. |
|
|
Source: The American Journal of Managed Care
|
|
|
4
|
PRICE TRANSPARENCY
| July 21 and 23, 2026
|
| House and Senate Advance Twin Price Transparency Bills |
| On July 21, the House Energy and Commerce Committee unanimously advanced H.R. 9393, the Lower Costs, More Transparency Act of 2026, absorbing ten additional healthcare bills into the base text during a full committee markup. Two days later, the Senate advanced the Patients Deserve Price Tags Act, sponsored by Sen. Roger Marshall (R-KS) and Sen. John Hickenlooper (D-CO), requiring hospitals and insurers to publicly post negotiated prices with real enforcement teeth. Hospital groups have signaled opposition to both bills. |
| |
MOC PERSPECTIVE
Simultaneous bipartisan movement in both chambers is the strongest signal since 2021 that hospital and insurer price transparency becomes codified statute rather than a rescindable rule. Codification removes the political risk that has kept plan sponsors from investing in machine-readable file infrastructure, and enforcement mechanisms will finally match the disclosure requirement.
|
|
| WHAT TO DO NOW |
| ▪ |
Stand up a permanent machine-readable file ingestion pipeline covering your top 25 in-network hospitals and top 5 PPO carriers. |
| ▪ |
Benchmark negotiated rates against Medicare plus 200 percent as the 2027 hard ceiling for inpatient and outpatient services. |
| ▪ |
Write codified transparency language into every 2027 hospital contract to lock in most-favored-nation and audit rights that survive any future carrier consolidation. |
|
|
Source: Alston and Bird, Health Care Week in Review
|
|
|
5
|
MEDICARE POLICY
| July 16, 2026
|
| Medicare Moves to End Payment for Outsourced Remote Monitoring |
| CMS published the CY 2027 Medicare Physician Fee Schedule proposed rule on July 16, and follow-up analysis has focused on a major structural change. Remote patient monitoring and remote therapeutic monitoring services would be payable only when furnished by clinical staff directly employed by the billing practice, ending the third-party vendor outsourcing that has grown rapidly since 2021. The rule also requires a dedicated initiating visit and eliminates practice expense inputs for remote monitoring management codes. Comments close September 14, 2026. |
| |
MOC PERSPECTIVE
The Medicare crackdown on remote monitoring previews what commercial payers will apply in 2028 renewals, because self-funded plans have been quietly absorbing the same third-party billing patterns Medicare now blocks. Remote monitoring claims on commercial plans grew roughly 300 percent from 2022 to 2025, and much of that growth came from staffing-agency clinical labor billed through provider NPIs.
|
|
| WHAT TO DO NOW |
| ▪ |
Audit your 2025 and 2026 remote monitoring claims for the ratio of enrolled devices to billed practitioner hours. |
| ▪ |
Require a direct-employment attestation on any remote monitoring claim above $50 in commercial contracts. |
| ▪ |
Use the CMS 2027 rule text as the template for a commercial coverage carve-out that pays only for practice-employed monitoring beginning January 2028. |
|
|
Source: CMS fact sheet, CY 2027 Physician Fee Schedule
|
| |
THE BOTTOM LINE
Four of the five items carry a 2027 or 2028 effective date. That timing is the whole story. Federal payers are moving cost, integrity, and disclosure risk down the chain, and the contracts you sign in the next two renewal cycles decide whether your plan prices that risk or absorbs it. Ask for the carve-outs, the caps, and the attestations now, while the terms are still open.
|
|
| Jude Odu |
| Founder and Principal, Model Optimal Care |
| |
|
Check your fiduciary risk
Run your plan through MOC Fiduciary Intelligence.
fiduciaryIQ.ai
|
|
| |
|
Get certified
CP-MOC founding cohort opens August 1, 2026.
cp-moc.academy
|
|
|
|
|
